Cargando…
Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes
Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (ami...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215857/ https://www.ncbi.nlm.nih.gov/pubmed/37238978 http://dx.doi.org/10.3390/biomedicines11051307 |
_version_ | 1785048162702983168 |
---|---|
author | Młynek, Mateusz Trzciński, Jakub Waldemar Ciach, Tomasz |
author_facet | Młynek, Mateusz Trzciński, Jakub Waldemar Ciach, Tomasz |
author_sort | Młynek, Mateusz |
collection | PubMed |
description | Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (amine, carboxyl, hydroxyl, etc.) makes them suitable materials for chemical modification or drug immobilisation. Among different drug delivery systems (DDSs), nanoparticles have been of great interest in scientific research in the last decades. In the following review, we want to address the issue of rational design of nanoparticle (NP)-based drug delivery systems in reference to the specificity of the medication administration route and resulting requirements. In the following sections, readers can find a comprehensive analysis of the articles published by authors with Polish affiliations in the last few years (2016–2023). The article emphasises NP administration routes and synthetic approaches, followed by in vitro and in vivo attempts toward pharmacokinetic (PK) studies. The ‘Future Prospects’ section was constructed to address the critical observations and gaps found in the screened studies, as well as to indicate good practices for polysaccharide-based nanoparticle preclinical evaluation. |
format | Online Article Text |
id | pubmed-10215857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102158572023-05-27 Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes Młynek, Mateusz Trzciński, Jakub Waldemar Ciach, Tomasz Biomedicines Review Polysaccharides are the most abundant polymers in nature. They exhibit robust biocompatibility, reliable non-toxicity, and biodegradable character; thus, they are employed in multiple biomedical applications. The presence of chemically accessible functional groups on the backbone of biopolymers (amine, carboxyl, hydroxyl, etc.) makes them suitable materials for chemical modification or drug immobilisation. Among different drug delivery systems (DDSs), nanoparticles have been of great interest in scientific research in the last decades. In the following review, we want to address the issue of rational design of nanoparticle (NP)-based drug delivery systems in reference to the specificity of the medication administration route and resulting requirements. In the following sections, readers can find a comprehensive analysis of the articles published by authors with Polish affiliations in the last few years (2016–2023). The article emphasises NP administration routes and synthetic approaches, followed by in vitro and in vivo attempts toward pharmacokinetic (PK) studies. The ‘Future Prospects’ section was constructed to address the critical observations and gaps found in the screened studies, as well as to indicate good practices for polysaccharide-based nanoparticle preclinical evaluation. MDPI 2023-04-28 /pmc/articles/PMC10215857/ /pubmed/37238978 http://dx.doi.org/10.3390/biomedicines11051307 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Młynek, Mateusz Trzciński, Jakub Waldemar Ciach, Tomasz Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title | Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title_full | Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title_fullStr | Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title_full_unstemmed | Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title_short | Recent Advances in the Polish Research on Polysaccharide-Based Nanoparticles in the Context of Various Administration Routes |
title_sort | recent advances in the polish research on polysaccharide-based nanoparticles in the context of various administration routes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215857/ https://www.ncbi.nlm.nih.gov/pubmed/37238978 http://dx.doi.org/10.3390/biomedicines11051307 |
work_keys_str_mv | AT młynekmateusz recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes AT trzcinskijakubwaldemar recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes AT ciachtomasz recentadvancesinthepolishresearchonpolysaccharidebasednanoparticlesinthecontextofvariousadministrationroutes |